Back
Intellia Therapeutics Stock Price Chart
Unlock the power of "two-minute trades"
Learn how today!
Sell
1
NTLA
Intellia Therapeutics
Last Price:
$10.18
Seasonality Move:
-8.17%
7 Day Trial
ALL ACCESS PASS
$
7
Free Stock Analysis: See What Your Stock is Really Worth
Analyze Any Stock Free-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NTLA is experiencing selling pressure, which indicates risk of future bearish movement.
Intellia Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 11.86 | Sell |
| 20-day SMA: | 12.33 | Sell |
| 50-day SMA: | 13.92 | Sell |
| 200-day SMA: | 20.66 | Sell |
| 8-day EMA: | 11.78 | Sell |
| 20-day EMA: | 12.44 | Sell |
| 50-day EMA: | 14.15 | Sell |
| 200-day EMA: | 20.26 | Sell |
Intellia Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.77 | Sell |
| Relative Strength Index (14 RSI): | 29.86 | Sell |
| Chaikin Money Flow: | -4616686 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (11.62 - 13.88) | Sell |
| Bollinger Bands (100): | (13.44 - 21.1) | Sell |
Intellia Therapeutics Technical Analysis
| Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | Jan 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | 08 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Intellia Therapeutics Stock
Is Intellia Therapeutics Stock a Buy?
-
Intellia Therapeutics share price is 10.20 while NTLA 8-day simple moving average is 11.86, which is a Sell signal.
-
The stock price of NTLA is 10.20 while Intellia Therapeutics 20-day SMA is 12.33, which makes it a Sell.
-
Intellia Therapeutics 50-day simple moving average is 13.92 while NTLA share price is 10.20, making it a Sell technically.
-
NTLA stock price is 10.20 and Intellia Therapeutics 200-day simple moving average is 20.66, creating a Sell signal.
NTLA Technical Analysis vs Fundamental Analysis
Sell
1
Intellia Therapeutics (NTLA)
is a Sell
Is Intellia Therapeutics a Buy or a Sell?
-
Intellia Therapeutics stock is rated a SellThe current Intellia Therapeutics [NTLA] share price is $10.20. The Score for NTLA is 1, which is 98% below its historic median score of 50, and infers higher risk than normal.
Intellia Therapeutics Stock Info
Market Cap:
1B
Price in USD:
10.20
Share Volume:
7.2M
Intellia Therapeutics 52-Week Range
52-Week High:
34.87
52-Week Low:
9.93
Sell
1
Intellia Therapeutics (NTLA)
is a Sell
Intellia Therapeutics Share Price Forecast
-
What is the Intellia Therapeutics stock price today?The Intellia Therapeutics stock price is 10.20 USD today.
-
Will NTLA stock go up or go down?Intellia Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Intellia Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Intellia Therapeutics is overvalued.
Is Intellia Therapeutics Stock a Buy?
-
Intellia Therapeutics share price is 10.20 while NTLA 8-day exponential moving average is 11.78, which is a Sell signal.
-
The stock price of NTLA is 10.20 while Intellia Therapeutics 20-day EMA is 12.44, which makes it a Sell.
-
Intellia Therapeutics 50-day exponential moving average is 14.15 while NTLA share price is 10.20, making it a Sell technically.
-
NTLA stock price is 10.20 and Intellia Therapeutics 200-day simple moving average is 20.26, creating a Sell signal.
Fundamental Analysis of Intellia Therapeutics
Is Intellia Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.13 per share, and a decrease next year of $0.01 per share.
Technical Analysis of Intellia Therapeutics
Should I short Intellia Therapeutics stock?
-
NTLA Moving Average Covergence Divergence (MACD) indicator is -0.77, suggesting Intellia Therapeutics is a Sell
-
Intellia Therapeutics Relative Strength Index (RSI) is 29.86, which suggest Intellia Therapeutics is oversold
-
The Bollinger Bands (25) for Intellia Therapeutics is (11.62 - 13.88), which suggest Intellia Therapeutics is a Sell
-
The Bollinger Bands (100) for Intellia Therapeutics is (13.44 - 21.1), which suggest Intellia Therapeutics is a Sell
* Intellia Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.